세계의 휴대용 초음파 기기 시장 : 시장 규모, 점유율, 동향 분석 보고서 - 용도별, 기술별, 지역별, 부문별 예측(2025-2030년)

Handheld Ultrasound Devices Market Size, Share & Trends Analysis Report By End Use (Hospitals, Primary Clinics), By Application (Trauma, Urology), By Technology (3D/4D, 2D, Doppler), By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,443,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,862,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,700,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

휴대용 초음파 기기 시장의 성장 및 동향 :

Grand View Research, Inc의 최신 보고서에 따르면 세계의 휴대용 초음파 기기 시장 규모는 2025년부터 2030년까지 연평균 복합 성장률(CAGR)은 5.74%를 기록할 전망이며, 2030년에는 4억 4,270만 달러에 달할 것으로 예측됩니다. 저침습 처치에 대한 환자의 선호도 증가, 의료 응급 상황에서 영상 진단 기기의 활용도 증가, 의료 기술의 급속한 진보가 시장 성장의 주요 요인입니다. 포인트 오브 케어 초음파 검사에 대한 주목의 고조 및 휴대용 초음파 기기의 즉각적이고 신속한 추정 능력이 시장 성장의 원동력이 되고 있습니다. 실시간 전송 및 이미지 기반 진단 시스템에 대한 수요가 증가하고 시장 확대에 기여하고 있습니다. 컴팩트한 크기로 인해 이러한 기기는 환자로 이동할 때 의사, 간호사 및 초음파 검사사에게 이상적입니다. 의사는 주머니와 폴더에 넣어 편안하게 운반할 수 있습니다.

또한, 무선 초음파 기기는 검출 및 치료를 위한 이미지 판독을 편리하게 했습니다. 따라서 이러한 기기를 사용하면 침습적인 수술과 관련된 합병증을 피할 수 있습니다. 그 결과, 외과의사는 휴대용 초음파 기기와 같은 비침습적 기술로 점점 이동하고 있습니다. 이러한 요인이 시장 성장을 가속할 것으로 예상됩니다. 진단 및 치료를 위한 제품 채용 증가가 시장 성장을 뒷받침하고 있습니다. 핸드헬드 초음파는 방광 용량, 복부 스크리닝, 산과, 근골격계, 초음파 가이드 하 치료 등 다양한 용도에서도 사용됩니다. 예를 들어, 2022년 7월 세계보건기구(WHO)의 보고에 따르면 세계 약 17억 1,000만 명이 근골격계 증상으로 고통받고 있습니다. 또한, 치료 휴대용 초음파 기기는 저침습 수술을 지원합니다.

휴대용 초음파 기기 시장 보고서 하이라이트 :

• 3D/4D 초음파 부문은 2024년에 약 46.69%의 최고 수익 점유율로 시장을 독점하였고, 2025년부터 2030년까지 6.16%의 최고 CAGR로 성장할 것으로 예측됩니다.
• 용도별로, 근골격계 부문은 2024년에 21.53%의 수익 점유율로 시장을 독점했습니다.
• 병원 부문은 2024년 42.09%의 최대 수익 점유율을 차지했습니다. 이 성장은 병원에서 실시되는 초음파 검사의 수와 유형이 다른 헬스케어 환경보다 많기 때문입니다.
• 2024년 세계 시장은 북미가 매출액에서 약 28.58%의 최대 점유율을 차지했습니다.

목차

제1장 조사 방법 및 범위

제2장 주요 요약

제3장 휴대용 초음파 기기 시장의 변수, 동향 및 범위

• 시장 계통 전망
  • 상위 시장 전망
  • 관련 및 부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 휴대용 초음파 기기 시장 분석 툴
  • 업계 분석 : Porter's Five Forces 분석
  • PESTEL 분석

제4장 휴대용 초음파 기기 시장 : 기술별 추정 및 동향 분석

• 기술별 시장 점유율(2024년, 2030년)
• 부문 대시보드
• 세계의 휴대용 초음파 기기 시장 : 기술별 전망
• 시장 규모, 예측 및 동향 분석(2018-2030년)
  • 2D 초음파
  • 3D/4D 초음파
  • 도플러 초음파

제5장 휴대용 초음파 기기 시장 : 용도별 추정 및 동향 분석

• 용도별 시장 점유율(2024년, 2030년)
• 부문 대시보드
• 세계의 휴대용 초음파 기기 시장 : 용도별 전망
• 시장 규모, 예측 및 동향 분석(2018-2030년)
  • 산부인과
  • 심장혈관
  • 비뇨기과
  • 소화기 내과
  • 근골격
  • 외상
  • 기타

제6장 휴대용 초음파 기기 시장 : 지역별 추정 및 동향 분석

• 지역별 시장 점유율 분석(2024년, 2030년)
• 지역별 시장 대시보드
• 세계의 지역별 시장 현황
• 시장 규모, 예측 및 동향 분석(2018-2030년)
• 북미
  • 규제 틀 및 상환 구조
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 규제 틀 및 상환 구조
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 스웨덴
  • 덴마크
• 아시아태평양
  • 규제 틀 및 상환 구조
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 규제 틀 및 상환 구조
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 규제 틀 및 상환 구조
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트

제7장 경쟁 구도

• 주요 시장 진출기업에 의한 최근의 동향 및 영향 분석
• 기업 및 경쟁의 분류
• 벤더 상황
  • 주요 고객
  • 주요 기업의 시장 점유율 분석(2024년)
  • GE HealthCare
  • Koninklijke Philips NV
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • BenQ Medical Technology
  • CHISON Medical Technologies Co., Ltd.
  • Dawei Medical(Jiangsu) Corp., Ltd.
  • Viatom Technology Co., Ltd.
  • Telemed Medical Systems Srl
  • Butterfly Network, Inc.
  • Pulsenmore Ltd.
  • Leltek Inc.

제8장 애널리스트의 시점

AJY

영문 목차

영문목차

Handheld Ultrasound Devices Market Growth & Trends:

The global handheld ultrasound devices market size is anticipated to reach USD 442.7 million by 2030, registering a CAGR of 5.74% from 2025 to 2030, according to a new report by Grand View Research, Inc. An increase in patient preference for minimally invasive procedures, rise in the utilization of imaging devices in medical emergencies, also rapid advancements in healthcare technology are key contributors to the market growth. The growing focus on point-of-care ultrasonography and the instantaneous and speedy estimating capabilities of handheld ultrasound devices drive the market growth. The demand for real-time delivery and image-based diagnostic systems has increased, contributing to the market's expansion. Due to their compact size, these devices are ideal for physicians, nurses, and sonographers when traveling to a patient. Doctors can carry them comfortably in their pockets or folders.

In addition, wireless ultrasound devices have made image-seizing for detection and treatment convenient. Hence, using these devices helps avoid complications associated with invasive surgeries. Consequently, surgeons increasingly shift toward noninvasive techniques, such as handheld ultrasound devices. These factors are expected to propel the growth of the market. The increasing product adoption for diagnosis and treatment is boosting the market growth. Handheld ultrasounds are also used in various applications, such as bladder volume, abdominal screening, obstetrics, musculoskeletal, and ultrasound-guided treatment. For instance, as per the World Health Organization (WHO) report of July 2022, about 1.71 billion people suffer from musculoskeletal conditions worldwide. Also, therapeutic handheld ultrasound devices support minimally invasive surgery.

Handheld Ultrasound Devices Market Report Highlights:

• The 3D/4D ultrasound segment dominated the market with the highest revenue share of around 46.69% in 2024, and it is expected to grow at the highest compound annual growth rate (CAGR) of 6.16% from 2025 to 2030.
• Based on application, the musculoskeletal segment dominated the market with a revenue share of 21.53% in 2024.
• The hospital segment held the largest revenue share of 42.09% in 2024. This growth can be attributed to the higher number and type of ultrasound studies performed in hospitals than in any other healthcare setting.
• North America dominated the global market in 2024 with the largest share of around 28.58% by revenue.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Technology
  • 1.2.2. Application
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Technology outlook
  • 2.2.2. Application outlook
  • 2.2.3. End use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Handheld Ultrasound Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing adoption of handheld ultrasound devices for diagnosis and treatment
    • 3.2.1.2. Rising demand for minimally invasive surgical procedures
    • 3.2.1.3. Technological advancements
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Lack of skilled professionals
    • 3.2.2.2. Limitations of the handheld ultrasound devices
• 3.3. Handheld Ultrasound Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Handheld Ultrasound Devices Market: Technology Estimates & Trend Analysis

• 4.1. Technology Market Share, 2024 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Handheld Ultrasound Devices Market by Technology Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.4.1. 2D Ultrasound
    • 4.4.1.1. 2D ultrasound market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. 3D/4D Ultrasound
    • 4.4.2.1. 3D/4D ultrasound market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Doppler Ultrasound
    • 4.4.3.1. Doppler ultrasound market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Handheld Ultrasound Devices Market: Application Estimates & Trend Analysis

• 5.1. Application Market Share, 2024 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Handheld Ultrasound Devices Market by Application Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.4.1. Obstetrics/Gynecology
    • 5.4.1.1. Obstetrics/Gynecology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Cardiovascular
    • 5.4.2.1. Cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. Urology
    • 5.4.3.1. Urology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.4. Gastroenterology
    • 5.4.4.1. Gastroenterology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.5. Musculoskeletal
    • 5.4.5.1. Musculoskeletal market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.6. Trauma
    • 5.4.6.1. Trauma market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.7. Others
    • 5.4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Handheld Ultrasound Devices Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.5. North America
  • 6.5.1. Regulatory framework/ reimbursement structure
  • 6.5.2. U.S.
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Competitive scenario
    • 6.5.2.3. Regulatory framework/ Reimbursement structure
    • 6.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Competitive scenario
    • 6.5.3.3. Regulatory framework/ Reimbursement structure
    • 6.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Competitive scenario
    • 6.5.4.3. Regulatory framework/ Reimbursement structure
    • 6.5.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Europe
  • 6.6.1. Regulatory framework/ reimbursement structure
  • 6.6.2. UK
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Competitive scenario
    • 6.6.2.3. Regulatory framework/ Reimbursement structure Regulatory framework/ Reimbursement structure
    • 6.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.3. Germany
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Competitive scenario
    • 6.6.3.3. Regulatory framework/ Reimbursement structure
    • 6.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.4. France
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Competitive scenario
    • 6.6.4.3. Regulatory framework/ Reimbursement structure
    • 6.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.5. Italy
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Competitive scenario
    • 6.6.5.3. Regulatory framework/ Reimbursement structure
    • 6.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.6. Spain
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Competitive scenario
    • 6.6.6.3. Regulatory framework/ Reimbursement structure
    • 6.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.7. Norway
    • 6.6.7.1. Key country dynamics
    • 6.6.7.2. Competitive scenario
    • 6.6.7.3. Regulatory framework/ Reimbursement structure
    • 6.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.8. Sweden
    • 6.6.8.1. Key country dynamics
    • 6.6.8.2. Competitive scenario
    • 6.6.8.3. Regulatory framework/ Reimbursement structure
    • 6.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.9. Denmark
    • 6.6.9.1. Key country dynamics
    • 6.6.9.2. Competitive scenario
    • 6.6.9.3. Regulatory framework/ Reimbursement structure
    • 6.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Regulatory framework/ reimbursement structure
  • 6.7.2. Japan
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Competitive scenario
    • 6.7.2.3. Regulatory framework/ Reimbursement structure
    • 6.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.3. China
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Competitive scenario
    • 6.7.3.3. Regulatory framework/ Reimbursement structure
    • 6.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.4. India
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Competitive scenario
    • 6.7.4.3. Regulatory framework/ Reimbursement structure
    • 6.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.5. Australia
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Competitive scenario
    • 6.7.5.3. Regulatory framework/ Reimbursement structure
    • 6.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.6. South Korea
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Competitive scenario
    • 6.7.6.3. Regulatory framework/ Reimbursement structure
    • 6.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.7. Thailand
    • 6.7.7.1. Key country dynamics
    • 6.7.7.2. Competitive scenario
    • 6.7.7.3. Regulatory framework/ Reimbursement structure
    • 6.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 6.8. Latin America
  • 6.8.1. Regulatory framework/ reimbursement structure
  • 6.8.2. Brazil
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Competitive scenario
    • 6.8.2.3. Regulatory framework/ Reimbursement structure
    • 6.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8.3. Argentina
    • 6.8.3.1. Key country dynamics
    • 6.8.3.2. Competitive scenario
    • 6.8.3.3. Regulatory framework/ Reimbursement structure
    • 6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 6.9. MEA
  • 6.9.1. Regulatory framework/ reimbursement structure
  • 6.9.2. South Africa
    • 6.9.2.1. Key country dynamics
    • 6.9.2.2. Competitive scenario
    • 6.9.2.3. Regulatory framework/ Reimbursement structure
    • 6.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9.3. Saudi Arabia
    • 6.9.3.1. Key country dynamics
    • 6.9.3.2. Competitive scenario
    • 6.9.3.3. Regulatory framework/ Reimbursement structure
    • 6.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9.4. UAE
    • 6.9.4.1. Key country dynamics
    • 6.9.4.2. Competitive scenario
    • 6.9.4.3. Regulatory framework/ Reimbursement structure
    • 6.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9.5. Kuwait
    • 6.9.5.1. Key country dynamics
    • 6.9.5.2. Competitive scenario
    • 6.9.5.3. Regulatory framework/ Reimbursement structure
    • 6.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Vendor Landscape
  • 7.3.1. Key customers
  • 7.3.2. Key company market share analysis, 2024
  • 7.3.3. GE HealthCare
    • 7.3.3.1. Company overview
    • 7.3.3.2. Financial performance
    • 7.3.3.3. Product benchmarking
    • 7.3.3.4. Strategic initiatives
  • 7.3.4. Koninklijke Philips N.V.
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. BenQ Medical Technology
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. CHISON Medical Technologies Co., Ltd.
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Dawei Medical (Jiangsu) Corp., Ltd.
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Viatom Technology Co., Ltd.
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. Telemed Medical Systems S.r.l.
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. Butterfly Network, Inc.
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Product benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. Pulsenmore Ltd.
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Product benchmarking
    • 7.3.12.4. Strategic initiatives
  • 7.3.13. Leltek Inc.
    • 7.3.13.1. Company overview
    • 7.3.13.2. Financial performance
    • 7.3.13.3. Product benchmarking
    • 7.3.13.4. Strategic initiatives

Chapter 8. Analyst Perspective

관련자료